FDA issues complete response letter for Pfizer’s tafamidis meglumine New Drug Application
18 June 2012 | By Pfizer
Tafamidis is a novel, investigational medication for the treatment of TTR-FAP...
List view / Grid view
News
Boehringer Ingelheim BioXcellence
18 June 2012 | By Boehringer Ingelheim
Boehringer Ingelheim BioXcellence: Distinctive brand for the biopharmaceutical contract manufacturing business...
Abbott presents results of clinical studies evaluating its investigational treatment for advanced Parkinson’s disease
18 June 2012 | By Abbott
Results from five abstracts announced...
AF patients who require surgery benefit from a shorter treatment interruption on dabigatran etexilate (Pradaxa®) compared to warfarin
18 June 2012 | By Boehringer Ingelheim
Pradaxa® is associated with a substantially shorter interruption of oral anticoagulation therapy...
USON promotes 18-year company leader to Global Sales Director
18 June 2012 | By ALM Communications Inc.
Dave Foran, President of USON, is pleased to announce the appointment of Gene Grilli to be USON Global Sales Director...
USON announces appointment of Charles D. Foran Jr. as company President
18 June 2012 | By ALM Communications Inc.
USON, announces the appointment of an award-winning veteran of the automated instrumentation industry, Charles D. Foran Jr. (Dave), as USON President...
Lonza announces successful completion of new GMP suite for growing viral vaccine and gene therapy business
Lonza, a global leader in the field of biologics manufacturing, today announced the successful completion of its new GMP clean room within its Houston, Texas operations. The clean room supports multiple types of viral vector and viral vaccine projects, with working volumes up to 2,000 liters.
U.S. District Court rules against Merck in NASONEX® (mometasone furoate monohydrate) patent lawsuit
15 June 2012 | By Merck
"While we are pleased with the court's ruling that the patent for NASONEX is valid..."
GSK continues with tender offer to acquire all outstanding shares of Human Genome Sciences
15 June 2012 | By GlaxoSmithKline
GSK has received a renewed invitation from Human Genome Sciences’...
Roche employees in 52 countries walk to raise funds to support vulnerable children worldwide
15 June 2012 | By Roche
Over 20,000 employees of Roche marked the International Day of the African Child...
Pfizer launches “Campaign Against Migraine”
15 June 2012 | By Pfizer
Pfizer has announced the launch of a new Web site, “Campaign Against Migraine”, to help migraine sufferers across the country...
GSK receives FDA approval for MenHibrix
14 June 2012 | By GlaxoSmithKline
First combination vaccine to help prevent meningococcal serogroups C and Y and Hib disease...
Teva announces top-line results from GALA Phase III trial
14 June 2012 | By Teva Pharmaceutical Industries Ltd
Teva announced positive top-line results from the GALA Phase III clinical trial assessing the efficacy, safety and tolerability...
Lundbeck plans to establish a more flexible commercial organisation in Europe
14 June 2012 | By H. Lundbeck A/S
Lundbeck proposes to restructure its commercial organisation in Europe to build a more flexible commercial infrastructure and to maintain cost control...
Cellectricon presented advanced cell-based assay systems at ELA 2012
13 June 2012 | By Alto Marketing
Speeding up research with novel cell manipulation and analysis platforms...
